Research points to the possibility of a new hybrid molecular imaging system that uses single photon emission tomography (SPECT) and magnetic resonance technology (MR). The new technology could provide a greater depth of information about an array of biological processes and anatomical information including soft-tissue contrast, which is important for many diagnoses.